These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21845187)

  • 1. Prevention of Post-ERCP Pancreatitis.
    Donnellan F; Byrne MF
    Gastroenterol Res Pract; 2012; 2012():796751. PubMed ID: 21845187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing post-ERCP pancreatitis: where are we?
    Testoni PA
    JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence, risk factors, and prevention of post-ERCP pancreatitis.
    Cooper ST; Slivka A
    Gastroenterol Clin North Am; 2007 Jun; 36(2):259-76, vii-viii. PubMed ID: 17533078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-ERCP pancreatitis: review of current preventive strategies.
    Feurer ME; Adler DG
    Curr Opin Gastroenterol; 2012 May; 28(3):280-6. PubMed ID: 22450899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectal indomethacin versus placebo to reduce the incidence of pancreatitis after endoscopic retrograde cholangiopancreatography: results of a controlled clinical trial.
    Andrade-Dávila VF; Chávez-Tostado M; Dávalos-Cobián C; García-Correa J; Montaño-Loza A; Fuentes-Orozco C; Macías-Amezcua MD; García-Rentería J; Rendón-Félix J; Cortés-Lares JA; Ambriz-González G; Cortés-Flores AO; Alvarez-Villaseñor Adel S; González-Ojeda A
    BMC Gastroenterol; 2015 Jul; 15():85. PubMed ID: 26195123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
    Cheng CL; Sherman S; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Lazzell-Pannell L; Rashdan A; Temkit M; Lehman GA
    Am J Gastroenterol; 2006 Jan; 101(1):139-47. PubMed ID: 16405547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.
    Sherman S; Alazmi WM; Lehman GA; Geenen JE; Chuttani R; Kozarek RA; Welch WD; Souza S; Pribble J;
    Gastrointest Endosc; 2009 Mar; 69(3 Pt 1):462-72. PubMed ID: 19231487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Post-ERCP pancreatitis.
    Arata S; Takada T; Hirata K; Yoshida M; Mayumi T; Hirota M; Yokoe M; Hirota M; Kiriyama S; Sekimoto M; Amano H; Wada K; Kimura Y; Gabata T; Takeda K; Kataoka K; Ito T; Tanaka M
    J Hepatobiliary Pancreat Sci; 2010 Jan; 17(1):70-8. PubMed ID: 20012323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unresolved issues about post-ERCP pancreatitis: an overview.
    Testoni PA
    JOP; 2002 Nov; 3(6):156-61. PubMed ID: 12432181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral allopurinol does not prevent the frequency or the severity of post-ERCP pancreatitis.
    Mosler P; Sherman S; Marks J; Watkins JL; Geenen JE; Jamidar P; Fogel EL; Lazzell-Pannell L; Temkit M; Tarnasky P; Block KP; Frakes JT; Aziz AA; Malik P; Nickl N; Slivka A; Goff J; Lehman GA
    Gastrointest Endosc; 2005 Aug; 62(2):245-50. PubMed ID: 16046988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Octreotide 24-h prophylaxis in patients at high risk for post-ERCP pancreatitis: results of a multicenter, randomized, controlled trial.
    Testoni PA; Bagnolo F; Andriulli A; Bernasconi G; Crotta S; Lella F; Lomazzi A; Minoli G; Natale C; Prada A; Toti GL; Zambelli A
    Aliment Pharmacol Ther; 2001 Jul; 15(7):965-72. PubMed ID: 11421871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis.
    Katsinelos P; Kountouras J; Paroutoglou G; Beltsis A; Mimidis K; Zavos C
    Gastrointest Endosc; 2005 Jul; 62(1):105-11. PubMed ID: 15990827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antioxidant supplementation for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
    Gu WJ; Wei CY; Yin RX
    Nutr J; 2013 Feb; 12():23. PubMed ID: 23398675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
    Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN
    Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does obesity confer an increased risk and/or more severe course of post-ERCP pancreatitis?: a retrospective, multicenter study.
    Deenadayalu VP; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Temkit M; Lehman GA; Sherman S
    J Clin Gastroenterol; 2008; 42(10):1103-9. PubMed ID: 18936645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does prophylactic administration of corticosteroid reduce the risk and severity of post-ERCP pancreatitis: a randomized, prospective, multicenter study.
    Sherman S; Blaut U; Watkins JL; Barnett J; Freeman M; Geenen J; Ryan M; Parker H; Frakes JT; Fogel EL; Silverman WB; Dua KS; Aliperti G; Yakshe P; Uzer M; Jones W; Goff J; Earle D; Temkit M; Lehman GA
    Gastrointest Endosc; 2003 Jul; 58(1):23-9. PubMed ID: 12838216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluid hydration to prevent post-ERCP pancreatitis in average- to high-risk patients receiving prophylactic rectal NSAIDs (FLUYT trial): study protocol for a randomized controlled trial.
    Smeets XJNM; da Costa DW; Fockens P; Mulder CJJ; Timmer R; Kievit W; Zegers M; Bruno MJ; Besselink MGH; Vleggaar FP; van der Hulst RWM; Poen AC; Heine GDN; Venneman NG; Kolkman JJ; Baak LC; Römkens TEH; van Dijk SM; Hallensleben NDL; van de Vrie W; Seerden TCJ; Tan ACITL; Voorburg AMCJ; Poley JW; Witteman BJ; Bhalla A; Hadithi M; Thijs WJ; Schwartz MP; Vrolijk JM; Verdonk RC; van Delft F; Keulemans Y; van Goor H; Drenth JPH; van Geenen EJM;
    Trials; 2018 Apr; 19(1):207. PubMed ID: 29606135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment.
    Pekgöz M
    World J Gastroenterol; 2019 Aug; 25(29):4019-4042. PubMed ID: 31413535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why the incidence of post-ERCP pancreatitis varies considerably? Factors affecting the diagnosis and the incidence of this complication.
    Testoni PA
    JOP; 2002 Nov; 3(6):195-201. PubMed ID: 12432186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-endoscopic retrograde cholangio-pancreatography pancreatitis: is time for a new preventive approach?
    Tammaro S; Caruso R; Pallone F; Monteleone G
    World J Gastroenterol; 2012 Sep; 18(34):4635-8. PubMed ID: 23002332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.